[HTML][HTML] Long COVID: pathophysiological factors and abnormalities of coagulation

S Turner, MA Khan, D Putrino, A Woodcock… - Trends in Endocrinology …, 2023 - cell.com
Acute COVID-19 infection is followed by prolonged symptoms in approximately one in ten
cases: known as Long COVID. The disease affects~ 65 million individuals worldwide. Many …

[HTML][HTML] Ethnic inequalities in COVID-19 infection, hospitalisation, intensive care admission, and death: a global systematic review and meta-analysis of over 200 …

P Irizar, D Pan, D Kapadia, L Bécares, S Sze… - …, 2023 - thelancet.com
Background COVID-19 has exacerbated existing ethnic inequalities in health. Little is known
about whether inequalities in severe disease and deaths, observed globally among …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

[HTML][HTML] Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK

E Rezel-Potts, A Douiri, X Sun, PJ Chowienczyk… - PLoS …, 2022 - journals.plos.org
Background Acute Coronavirus Disease 2019 (COVID-19) has been associated with new-
onset cardiovascular disease (CVD) and diabetes mellitus (DM), but it is not known whether …

[HTML][HTML] Long COVID: a review and proposed visualization of the complexity of long COVID

R Perumal, L Shunmugam, K Naidoo… - Frontiers in …, 2023 - frontiersin.org
Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus–2 (SARS-CoV-2)
infection, or Long COVID, is a prevailing second pandemic with nearly 100 million affected …

Thromboinflammation in long COVID—the elusive key to postinfection sequelae?

L Nicolai, R Kaiser, K Stark - Journal of Thrombosis and Haemostasis, 2023 - Elsevier
Long COVID is a public health emergency affecting millions of people worldwide,
characterized by heterogeneous symptoms across multiple organ systems. Here, we discuss …

Clinical course and management of COVID-19 in the era of widespread population immunity

EA Meyerowitz, J Scott, A Richterman, V Male… - Nature Reviews …, 2024 - nature.com
The clinical implications of COVID-19 have changed since SARS-CoV-2 first emerged in
humans. The current high levels of population immunity, due to prior infection and/or …

Platelets and SARS-CoV-2 during COVID-19: immunity, thrombosis, and beyond

A Sciaudone, H Corkrey, F Humphries… - Circulation …, 2023 - Am Heart Assoc
COVID-19 is characterized by dysregulated thrombosis and coagulation that can increase
mortality in patients. Platelets are fast responders to pathogen presence, alerting the …

[HTML][HTML] COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records

JH Thygesen, C Tomlinson, S Hollings… - The Lancet Digital …, 2022 - thelancet.com
Background Updatable estimates of COVID-19 onset, progression, and trajectories underpin
pandemic mitigation efforts. To identify and characterise disease trajectories, we aimed to …

Severe infection and risk of cardiovascular disease: a multicohort study

PN Sipilä, JV Lindbohm, GD Batty, N Heikkilä… - Circulation, 2023 - Am Heart Assoc
Background: The excess risk of cardiovascular disease associated with a wide array of
infectious diseases is unknown. We quantified the short-and long-term risk of major …